Multi-disciplinary Care for Brain Metastases

Status Recruiting

Clinical Trial Summary

This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.

Clinical Trial Description

This is a cohort study of patient with newly diagnosed brain metastases assigned to standard of care (SOC) or intensive multi-disciplinary care (IMDC). Care for all patients with brain metastases involves complex medical decision making and requires input for multiple stakeholders, including medical oncology, neurosurgery, radiation oncology, and neuro-oncology. Palliative care should be an essential component of the care team for all patients with brain metastases by the very nature of this advanced malignancy. At the University of Vermont, our current process for diagnosis and management of patients with brain metastases relies heavily on the physician and team who make the initial diagnosis to consult others as they see appropriate. This process may look different for different patients. We rationalize that a systematic approach with intensive multidisciplinary care (IMDC) will benefit patients with brain metastases by providing consistent access to multi-disciplinary discussion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06280300
Study type	Interventional
Source	University of Vermont Medical Center
Contact	Alissa A Thomas, MD
Phone	802-847-8400
Email	athoma21@med.uvm.edu
Status	Recruiting
Phase	N/A
Start date	November 16, 2023
Completion date	November 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05428852` - Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases	N/A
Recruiting	`NCT05559853` - Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
Recruiting	`NCT05689619` - SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)	N/A
Recruiting	`NCT04197297` - Brain Imaging Biomarkers in Patients With Brain Metastasis	Phase 2
Recruiting	`NCT04397978` - Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases
Terminated	`NCT04434560` - Neoadjuvant Immunotherapy in Brain Metastases	Phase 2
Active, not recruiting	`NCT05095766` - Comparaison Between MRI Alone or Combined With Positron Emission Tomography for Brain Metastasis Diagnosis
Recruiting	`NCT05012254` - Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases	Phase 2
Recruiting	`NCT05789589` - Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases	Phase 1/Phase 2
Recruiting	`NCT06047379` - Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis	Phase 1/Phase 2
Completed	`NCT03896555` - Intrafractional Head Movement During Radiosurgery
Terminated	`NCT03789149` - Focal Intraoperative Radiotherapy of Brain Metastases	Phase 2
Recruiting	`NCT04343157` - UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases	Phase 2
Recruiting	`NCT04711824` - Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases	Phase 1/Phase 2
Recruiting	`NCT05793489` - Prospective Double Arm Randomized Trial: WBRT Alone and WBRT Plus Silibinin	N/A
Recruiting	`NCT04461418` - Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases	Phase 2
Recruiting	`NCT03818386` - Radiotherapy of Multiple Brain Metastases Using AGuIX®	Phase 2
Active, not recruiting	`NCT05087095` - Managing Distress in Malignant Brain Cancer	N/A
Recruiting	`NCT04396717` - Safety Study of Pritumumab in Brain Cancer	Phase 1
Recruiting	`NCT06231186` - a Feasibility Study of iHD-SRT for BM	N/A